Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance
Novartis Delivers Solid Growth in Q3 Novartis, an innovative medicines company, has reported solid sales and core operating income growth in Q3, along with strong pipeline progress.